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Abstract  
Shigella is a common cause of diarrhoea in Papua New Guinea (PNG) and other 
Oceania countries. However, little is known about the strains causing infection. 
Archived Shigella isolates (n=72) were obtained from research laboratories in PNG 
and reference laboratories in Australia. Shigella virulence genes were detected by 
PCR, and antimicrobial susceptibility was determined by disk diffusion. The ipaH 
virulence gene was present in all 72 isolates. The prevalence of other virulence 
genes was variable, with ial, invE, ipaBCD, sen/ospD3 and virF present in 60% of 
isolates and set1A and set1B genes present in 42% of isolates. Most S. flexneri 
isolates contained genes encoding enterotoxin 1 and/ or enterotoxin 2. Resistance to 
antibiotics was common, with 51/72 isolates resistant to 2-4 antimicrobials. A greater 
proportion of bacteria isolated since 2010 (relative to pre-2010 isolates) were 
resistant to commonly used antibiotics such as ampicillin, chloramphenicol, 
tetracycline, and trimethoprim-sulfamethoxazole; suggesting that antimicrobial 
resistance (AMR) in Shigella is increasing over time in the Oceania region. There is 
a need for improved knowledge regarding Shigella circulation in the Oceania region 
and further monitoring of AMR patterns. 
Abbreviations: 
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AMR: antimicrobial resistance 
DNA: Deoxyribonucleic acid 
MDR: multi-drug resistant 
PCR: polymerase chain reaction 
PNG: Papua New Guinea 
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Main text  
Shigellosis is a leading global cause of moderate-severe diarrhoea in children 
(Bardhan et al. 2010) and adults (Lozano et al. 2012), affecting ~125 million people 
per year. There are four species of Shigella, each with their own epidemiological 
characteristics. S. flexneri is responsible for most of the shigellosis burden in 
developing countries globally; with S. boydii also important, but largely confined to 
the Indian subcontinent. S. dysenteriae causes sporadic, epidemic outbreaks of 
diarrhoea, especially in areas experiencing conflict and natural disasters (Kotloff et 
al. 1999). S. sonnei occurs predominantly in developed countries and in countries 
transitioning from low- to middle-income (Niyogi 2005; Taneja and Mewara 2016).  
 
Papua New Guinea (PNG) is the only low/middle income country in the Oceania 
region for which recent reports on shigellosis exist, with evidence that Shigella is an 
important cause of enteric disease in adults (Greenhill et al. 2014), children (Howard 
et al. 2000; Soli et al. 2014) and vulnerable populations (Benny et al. 2014). Little is 
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known about the genetic traits or virulence of Shigella strains circulating in the 
Oceania region, beyond the sporadic documentation of antibiotic resistance to many 
commonly used antibiotics such as ampicillin, chloramphenicol, tetracycline and 
trimethoprim-sulfamethoxazole (Greenhill et al. 2014; Rosewell et al. 2010; Storch et 
al. 1980; Watson 2006). In this study, we sought to gain a greater understanding of 
Shigella isolated from PNG and nearby Oceania countries, looking specifically at the 
presence of virulence genes and antibiotic resistance. 
 
Seventy-two Shigella isolates from PNG (n=60) and neighbouring Pacific Island 
nations (n=12) were analysed. Of the PNG isolates: 30 were from a study previously 
conducted by our research team (Greenhill et al. 2014); one was from a recent 
outbreak of shigellosis in PNG (Benny et al. 2014); seven isolates were from a 
previous case-control study conducted in PNG (Howard et al. 2000); and the 
remaining isolates (n = 22) were from travellers returning to Australia from PNG. The 
12 non-PNG isolates were from travellers returning to Australia from Pacific Island 
nations (Fiji, Vanuatu, Samoa, Solomon Islands), including three isolates from 
people who lived in or had spent time in the Torres Strait Islands (situated north of 
mainland Australia). The study collection comprised 53 S. flexneri isolates (from 
1985-2014), 16 S. sonnei isolates (from 1999-2015) and three S. dysenteriae 
isolates (from 1985 and 2010). 
 
Isolates were cultured on nutrient agar and incubated overnight at 37°C prior to DNA 
extraction (FavorPrep Tissue Genomic DNA Extraction Mini Kit, Favorgen, Taiwan), 
and antibiotic susceptibility testing. Isolates had previously been confirmed as 
Shigella and speciated using poly-O antisera; all 72 isolates were confirmed as 
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Shigella by real-time PCR detection of the ipaH gene (Lin et al. 2010) prior to further 
analyses. Approximately half (56%) the isolates were serotyped/biotyped. 
 
Conventional PCR (Table 1) was used to confirm the presence/absence of known 
Shigella virulence genes: ipaBCD and ipaH (invasion plasmid antigen BCD and H 
genes); ial (invasion-associated locus); virF and invE (regulators for transcription 
activation on the virulence plasmid); set1A and set1B (Shigella enterotoxin 1 genes); 
and sen/ospD3 (Shigella enterotoxin 2 gene). Amplicons were visualised by gel 
electrophoresis. 
 
Isolates were tested for antibiotic susceptibility by disk diffusion following the Clinical 
Laboratory Standards Institute guidelines (CLSI 2015), using Escherichia coli ATCC 
25922 as a control. Antibiotics assayed were ampicillin (10 μg), ceftriaxone (30 μg), 
chloramphenicol (30 μg), ciprofloxacin (5 μg), nalidixic acid (30 μg), tetracycline 
(30 μg) and trimethoprim-sulfamethoxazole (25 μg). 
 
Isolates of each species were grouped according to their virulence gene profiles 
(presence/absence of genes), producing four groups of S. flexneri, two groups of 
S. sonnei and a single group of S. dysenteriae (Table 2). Detailed statistical analyses 
were not conducted due to opportunistic sample collection, but a trend for more 
recent S. flexneri isolates to harbour more virulence genes was noted. In particular, 
genes coding for Shigella enterotoxin 1 (set1A and set1B) were detected only in 
isolates obtained since 2009. All isolates positive for set1A and set1B were from 
PNG, or from the Torres Strait Islands - a region of Australia with close geographical 
and cultural links to PNG.  
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The enterotoxin genes are primarily responsible for the clinical manifestation of 
acute-watery diarrhoea and dysentery in shigellosis. Genes encoding Shigella 
enterotoxin 1 (set1A and set1B) were present in S. flexneri serotype 2a isolates 
collected from 2009 onwards (~57% of S. flexneri isolates) but not detected in either 
S. sonnei or S. dysenteriae. These genes have been detected at similar rates in 
paediatric cases in the Brazilian Amazon (da Cruz et al. 2014) and in northeastern 
Brazil (Mendeiros et al, 2018), but at lower rates in comparable studies in Argentina 
(Casabonne et al. 2016). No published studies have investigated virulence genes in 
Shigella from the Oceania region, and relatively few in Asia. In China a similar 
species distribution of the set gene was observed in Beijing, being commonly 
detected in S. flexneri (88% of isolates, thus more frequently than in PNG isolates), 
but infrequently in other species (Qu et al, 2014). In a study conducted in Eastern 
China set-1A and set-1B genes were detected in 74.5% and 78% of S. flexneri, 
respectively (Fan et al, 2017) In our study Shigella enterotoxin 2 genes (sen/ospD3) 
were present in 79% of S. flexneri isolates, a detection rate higher than two 
comparable studies conducted in South America (da Cruz et al. 2014; Casabonne et 
al. 2016) but lower than detected in S. flexneri isolates from northeastern Brazil 
(Medeiros et al, 2018). One isolate of S. sonnei harboured sen/ospD3, which has 
been reported previously (da Cruz et al. 2014; Casabonne et al. 2016); and indeed 
appears common in parts of Brazil (Medeiros et al, 2018) and China (Qu et al, 2014; 
Fan et al, 2017). The high prevalence of both enterotoxin encoding genes in 
circulating strains of S. flexneri could have public health ramifications in PNG, where 
access to healthcare is often limited.  
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The Shigella invasion plasmid is a large unstable plasmid that encodes several 
virulence genes, including ipaH, ipaBCD, virF, invE and ial; the ipaH gene is also 
chromosomally encoded, so is considered a stable target gene. The ipaH gene was 
present in all isolates, while 60% of isolates contained all four ipaBCD, virF, invE and 
ial genes (Table 2). It is important to note that the latter virulence genes (ipaBCD, 
virF, invE and ial) all contribute to facilitating and maintaining the spread and survival 
of Shigella during infection (Broach et al, 2012; Lluque et al. 2015; Schroeder et al, 
2008). Our results suggest that there is a strong association between all of these 
genes, as they were invariably present/absent as a set (Table 2). In regards to the 
stability of these invasion plasmid virulence genes, some studies have shown that 
the ial gene in particular is prone to deletion (Zhang et al, 2013). 
 
While recently circulating isolates tended to have an increased number of virulence 
genes, S. flexneri isolates with different virulence gene profiles were isolated as 
recently as 2012-14, suggesting co-circulation of strains.  A study of global isolates 
of S. flexneri using whole genome sequencing revealed old and new strains of S. 
flexneri to persist alongside one another and continue causing infection (Connor et 
al. 2015).  
 
S. flexneri isolates were frequently resistant to ampicillin (77%), tetracycline (74%), 
chloramphenicol (60%) and trimethoprim-sulfamethoxazole (49%). S. sonnei 
resistance to trimethoprim-sulfamethoxazole (75%) and ampicillin (56%) was 
common, followed by tetracycline (19%) and nalidixic acid (6%). S. dysenteriae also 
displayed resistance to ampicillin, tetracycline and trimethoprim-sulfamethoxazole 
(33%) (Table 3).  
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An increase in the prevalence of antimicrobial drug resistance to older antimicrobials, 
namely ampicillin, tetracycline, chloramphenicol and trimethoprim-sulfamethoxazole 
(Figure 1), was observed in post-2010 isolates compared to pre-2010 isolates. Few 
comparable data exist in the Oceania region, but this increase in antimicrobial drug 
resistance coincides with findings in Fiji, where there is evidence of ampicillin and 
chloramphenicol AMR rates increasing over time, especially in S. flexneri (Watson 
2006). Our observed trend of increasing AMR in Shigella is also reflected in other 
low-income settings. In Mozambique, Shigella isolates are commonly resistant to the 
same antibiotics to which resistance was observed in this study (Mandomando et al, 
2009). Multidrug resistance (MDR), defined as resistance to at least two 
antimicrobials, was detected in 71% (n=51) of isolates. Using a more stringent 
definition (resistance to at least three antimicrobials), MDR was detected in 54% 
(n=39) of isolates (Table 4); a rate also similar to that observed in Mozambique 
(Mandomando et al, 2009). 
 
Resistance to ciprofloxacin or ceftriaxone was not observed in any Shigella isolates 
in this study; however, one S. sonnei isolate was resistant to nalidixic acid. 
Ciprofloxacin resistance in S. flexneri strains and nalidixic acid resistance in S. 
sonnei is increasingly reported in Asia and Africa (Gu et al. 2012). Given the close 
proximity of Asia to Oceania, the possibility of AMR strains being introduced into the 
Oceania region is a cause for concern and warrants monitoring. 
 
This study provides initial data on the distribution of Shigella virulence genes in PNG 
and neighbouring Pacific Islands and provides insight into the AMR trends. It is 
9 
 
notable that many of the recently isolated S. flexneri harbour more virulence genes 
than most pre-2009 isolates. Similarly, there appears to be increasing resistance to 
commonly used antibiotics. Further genetic typing is required to determine whether 
these represent new strains; or they are the same strains which have acquired 
genetic elements associated with virulence and antibiotic resistance. There is a need 
to monitor Shigella strains in the region to enable better management of clinical 
cases and to reduce morbidity and mortality in vulnerable populations of the Oceania 
region. 
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Table 1. List of standard PCR primers used for the detection of Shigella virulence genes. 1 
 2 
Gene target Primers Annealing temp. °C Amplicon size (bp) Reference 
ipaH ipaH_F1: GCTGGAAAAACTCAGTGCCT 56 424 Tornieporth et al., 1995 
ipaH_R1: CCAGTCCGTAAATTCATTCT 
ial ial_F: CTGGATGGTATGGTGAGG 58 320 Talukder et al., 2007 
ial_R: GGAGGCCAACAATTATTTCC 
invE invE_F: CGATAGATGGCGAGAAATTATATCCCG 57 766 Muller et al., 2007 
invE_R: CGATCAAGAATCCCTAACAGAAGAATCAC 
ipaBCD ipaBCD_F: GCTATAGCAGTGACATG 55 500 Faruque et al., 2002 
ipaBCD_R: ACGAGTTCGAAGCACTC 
sen/ospD3 sen/ospD3_F: ATGTGCCTGCTATTATTTAT 54 799 Talukder et al., 2007 
sen/ospD3_R: CATAATAATAAGCGGTCAGC 
set1A set1A_F: TCACGCTACCATCAAAGA 57 309 Talukder et al., 2007 
set1A_R: TATCCCCCTTTGGTGGTA 
set1B set1B_F: GTGAACCTGCTGCCGATATC 57 147 Talukder et al., 2007 
set1B_R: ATTAGTGGATAAAAATGACG 
virF virF_F: TCAGGCAATGAAACTTTGAC 58 618 Gomez-Duarte et al., 2009 
virF_R: TGGGCTTGATATTCCGATAAGTC 
  3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
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Table 2. Virulence profiles based on presence/absence of virulence genes in Shigella by species 12 
Species ipaH 
sen/osp
D3 set1A set1B invE ial ipaBCD virF 
Year of 
Isolation 
No. 
Isolates Serotype 
 
Biotype Origin 
S. 
flexneri 
+ + - - + + + + 
1985 1 3  PNG 
1994 1 2a  PNG 
2002 1 6  PNG 
2006 1 3a  PNG 
2006 1 2a  PNG 
2007 1 3a  PNG 
2007 1 1b  Fiji 
2010 4  nt   PNG 
2011 1  nt  PNG 
2012 1 X  Samoa 
S. 
flexneri 
+ - - - - - - - 
1985 3 1  PNG 
1985 1 3  PNG 
1992 1       nt  PNG 
2000 1 2a  PNG 
2004 1 1b  PNG 
2010 3        nt  PNG 
S. 
flexneri 
+ - + + - - - - 
2009 1 2a 
 
PNG 
S. 
flexneri 
+ + + + + + + + 
2009 1 2a 
 Torres 
Strait 
2010 1 2a 
 Torres 
Strait 
18 
 
2010 20 nt   PNG 
2011 2 2a  PNG 
2013 1 2a 
 Torres 
Strait 
2013 3 2a  PNG 
2014 1 X  PNG 
S. 
sonnei 
+ - - - - - - - 
1999 1 
 
 a PNG 
2007 1  a 
Solomon 
Islands 
2008 1  g PNG 
2011 2  g PNG 
2012 3  a Fiji 
2013 1  a Samoa 
2013 1  a Vanuatu 
2014 3  g PNG 
2015 1  g PNG 
2015 1  a Vanuatu 
S. 
sonnei + + - - + + + + 2010 1  f PNG 
S. 
dysente
riae 
+ - - - - - - - 
1985 1  nt  PNG 
2010 2  nt 
 
PNG 
Legend: nt not tested; PNG Papua New Guinea 13 
 14 
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Table 3. Proportion of Shigella isolates resistant to selected antimicrobials. 16 
Number of Shigella species (%) with – antimicrobial resistance 
 Antimicrobial S. flexneri  
(n=53) 
S. sonnei  
(n=16) 
S. dysenteriae 
(n=3) 
Total (%) 
(n=72) 
AMP 41 (77) 9 (56) 1 (33) 51 (71) 
CHL 32 (60) 0 0 32 (44) 
CIP 0 0 0 0 
CRO 0 0 0 0 
NAL 0 1 (6) 0 1 (1) 
TET 39 (74) 3 (19) 1 (33) 43 (60) 
SXT 26 (49) 12 (75) 1 (33) 39 (54) 
Legend: Ampicillin (AMP), Chloramphenicol (CHL), Ciprofloxacin (CIP), Nalidixic acid (NAL), Tetracycline (TET), 17 
trimethoprim-sulfamethoxazole (SXT). 18 
 19 
Table 4. Antibiotic resistance profiles of Shigella isolates. 20 
  S. flexneri  S. sonnei   S. dysenteriae   
 
Total (%) 
 
AMP/CHL/TET/
SXT 
17 (32) 0 0 17 (24) 
AMP/CHL/TET 12 (23) 0 0 12 (17) 
AMP/SXT 1 (2) 7 (44) 1 (33) 9 (13) 
AMP/TET/SXT 4 (8) 2 (13) 0 6 (8) 
AMP/TET 3 (6) 0 0 3 (4) 
CHL/TET/SXT 2 (4) 0 0 2 (3) 
AMP/CHL/SXT 1 (2) 0 0 1 (1) 
NAL/TET/SXT 0 1 (6) 0 1 (1) 
AMP 3 (6) 0 0 3 (4) 
TET 1 (2) 0 1 (33) 2 (3) 
SXT 1 (2) 2 (13) 0 3 (4) 
Susceptible 8 (15) 4 (25) 1 (33) 13 (18) 
Total 53 16 3 72 
 21 
 22 
20 
 
 23 
Figure 1. Proportion of isolates (%) isolated before and after 2010 that are 24 
susceptible or resistant to selected antibiotics. The post-2010 group includes isolates 25 
from 2010. 26 
 27 
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